Dear colleagues

I have been following with keen interest this very well structured and
managed e-conference, with very insightful expert views. My small
contribution at this stage of the conference will be built on my more than
15 years in vaccine development and production, which have covered also the
PPR vaccine. Including PPR in a combination or multivalent vaccine for small
ruminants is undoubtedly the approach that will address many disease
management, logistical and access challenges in most developing countries.
It is equally clear that the combinations to be considered should take into
account the situation of each regions in terms of disease prevalence.
Combining vaccines has always been a tricky decision for vaccine
manufacturers. One have to take into account for example the need to avoid
combining a "public good" disease vaccine with a "production disease
vaccine". This would compromise the commercial value of one of them, as
their commercialisation strategy are different (tender versus direct sales
etc.). There is also the risk of cannibalising the market of one of them. 

There are also technical and compatibility aspects that have been covered by
many contributors, including Niwael. The authoritative intervention by Dr.
Tounkara is also a strong basis to consider when deciding on combination
strategy.  

Over the past 5 years while in GALVmed, we were promoting jointly with many
other colleagues  the need to use Target Product profiles (TPP) as the basis
for developing products that meet the real needs of the users, but also
address everybody's concerns.  One of my recommendations for this session of
the e-conference would therefore be that, all having agreed on the need for
combination vaccines appropriate for different regions, that consensus TPPs
be developed for the different combinations, maybe starting with the most
commonly recommended one, which is PPR-S/GP. The consensus in developing
such a TPP should be obtained from field experts, disease (or PPR virus)
researchers, industry and veterinary services. 

This could be one very useful outcome of the conference

 

Best wishes

 

Baptiste Dungu DVM PhD

 


########################################################################

To unsubscribe from the FAO-AnimalHealth-L list, click the following link:
https://listserv.fao.org/cgi-bin/wa?SUBED1=FAO-AnimalHealth-L&A=1